A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients

Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension

SEL24/MEN1703 in Patients With Acute Myeloid Leukemia

Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis

A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary Sarcoidosis

Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

A Study of Atezolizumab (Anti−Pd-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

OLAParib COmbinations